FLGT News and Press, Fulgent Genetics Inc. From 04/03/20

Fulgent Genetics (FLGT) had a very good 2019, but it won't come as a surprise to realize that 2020 is going to be considerably more challenging. At the time of the Q4CC (March 10), the US was still a different place, so management did not see much impact of the coronavirus. In fact, they wer...

Medtronic Gets Patent Challenge from Axonics Medtronic Plc ( MDT ) saw a small setback as Axonics Modulation Technologies filed a petition with the United States Patents and Trademark Office against one of its patents. The petitions contest the validity of Medtronic's patent related to s...

BioNTech SE (NASDAQ: BNTX ) +55%  on teaming up with Pfizer teams to develop COVID-19 vaccine. More news on: BioNTech SE, Co-Diagnostics, Inc., Neon Therapeutics, Inc., Stocks on the move, , Read more ...

Fulgent Genetics (NASDAQ: FLGT ) is up  26%  premarket on the launch of Next Generation Sequencing (NGS) based test for the Coronavirus Disease (COVID-19). More news on: Fulgent Genetics, Inc., Healthcare stocks news, Stocks on the move, Read more ...

TEMPLE CITY, Calif., March 17, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a provider of comprehensive genetic testing and Next Generation Sequencing (“NGS”) solutions, today announced the la...

Gainers:  Tiziana Life Sciences TLSA  +163% . More news on: Allied Healthcare Products, Inc., Akerna Corp., Inovio Pharmaceuticals, Inc., Stocks on the move, , Read more ...

Fulgent Genetics, Inc. (FLGT) Q4 2019 Earnings Conference Call March 10, 2020 16:30 ET Company Participants Nicole Borsje - Head, IR Ming Hsieh - CEO Paul Kim - CFO Brandon Perthuis - Chief Commercial Officer Conference Call Participants Presentation Operator Ladi...

Fulgent Genetics (NASDAQ: FLGT ): Q4 Non-GAAP EPS of $0.04 beats by $0.02 ; GAAP EPS of -$0.01 misses by $0.03 . More news on: Fulgent Genetics, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

Fourth Quarter 2019 Results : Revenue totals $8.4 million, growing 48% year over year Billable tests delivered total 13,977, growing 118% year over year Gross Margin improves more than 5 percentage points year over year; cost per test improves approximately 40% year over year GAAP l...

TEMPLE CITY, Calif., March 10, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a provider of comprehensive genetic testing and Next Generation Sequencing (“NGS”) solutions, today announced the pr...